Erythrocyte membrane antigen frequencies in patients with Type II congenital smell loss.

Am J Otolaryngol

Department of Transfusion Medicine, NIH Clinical Center, 10 Center Drive-MSC 1184, Building 10, Room 1C711, Bethesda, MD, United States. Electronic address:

Published: November 2015

Objective: The objective of this study was to determine whether there are genetic factors associated with Type II congenital smell loss.

Study Design: The expression frequencies of 16 erythrocyte antigens among patients with Type II congenital smell loss were determined and compared to those of a large control group.

Methods: Blood samples were obtained from 99 patients with Type II congenital smell loss. Presence of the erythrocyte surface antigens A, B, M, N, S, s, Fy(a), Fy(b), D, C, c, E, e, K, Jk(a), and Jk(b) was analyzed by blood group serology. Comparisons of expression frequencies of these antigens were made between the patients and a large control group.

Results: Patients tested for the Duffy b antigen (Fy(b) haplotype) exhibited a statistically significant 11% decrease in expression frequency compared to the controls. There were no significant differences between patients and controls in the expression frequencies for all other erythrocyte antigens (A, B, M, N, S, s, Fy(a), D, C, c, E, e, K, Jk(a), or Jk(b)).

Conclusions: These findings describe the presence of a previously unrevealed genetic tendency among patients with Type II congenital smell loss related to erythrocyte surface antigen expression. The deviation in expression rate of Duffy b suggests a target gene and chromosome region in which future research into this form of congenital smell loss may reveal a more specific genetic basis for Type II congenital smell loss.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330100PMC
http://dx.doi.org/10.1016/j.amjoto.2014.10.006DOI Listing

Publication Analysis

Top Keywords

congenital smell
28
type congenital
24
smell loss
24
patients type
16
expression frequencies
12
frequencies erythrocyte
8
erythrocyte antigens
8
antigens patients
8
large control
8
erythrocyte surface
8

Similar Publications

Kallmann syndrome is a rare disorder characterized by hypogonadotropic hypogonadism and an impaired sense of smell (anosmia or hyposmia) caused by congenital defects in the development of the gonadotropin-releasing hormone (GnRH) and olfactory neurons. Mutations in several genes have been associated with Kallmann syndrome. However, genetic testing of this disorder often reveals variants of uncertain significance (VUS) that remain uninterpreted without experimental validation.

View Article and Find Full Text PDF

Background: Congenital lung malformations (CLMs) are among the rare anomalies that can be diagnosed by bronchoscopy and imaging. They can cause various respiratory symptoms and complications, especially in children with congenital heart disease. This is an interesting case report of a child with a rare combination of congenital anomalies affecting the airway.

View Article and Find Full Text PDF

Hypogonadotropic hypogonadism as a cause of NOA and its treatment.

Asian J Androl

October 2024

Section of Andrology, Department of Urology, Istanbul School of Medicine, Istanbul 34093, Türkiye.

Hypogonadotropic hypogonadism (HH) represents a relatively rare cause of nonobstructive azoospermia (NOA), but its knowledge is crucial for the clinical andrologists, as it represents a condition that can be corrected with medical therapy in 3 quarters of cases. There are forms of congenital HH, whether or not associated with an absent sense of smell (anosmic HH or Kallmann syndrome, and normosmic HH, respectively), and forms of acquired HH. In congenital HH, complete absence of pubertal development is characteristic.

View Article and Find Full Text PDF

Humans without a sense of smell breathe differently.

Nat Commun

October 2024

The Azrieli National Institute for Human Brain Imaging and Research, Weizmann Institute of Science, Rehovot, Israel.

Article Synopsis
  • Olfaction may seem limited in influencing human behavior, but losing the sense of smell (anosmia) can lead to serious negative effects, including a shorter lifespan.
  • The study investigates how anosmia affects nasal airflow patterns using a wearable device that tracks breathing over 24 hours in individuals with and without anosmia.
  • Findings show that airflow patterns differ significantly in those with anosmia, which could explain some health and emotional issues linked to the condition, suggesting that altered breathing may be a bigger factor than just the inability to perceive smells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!